Login

Jungheinrich CEO: From Challenges to Comeback | Lars Brzoska - CEO of Jungheinrich 00:10:00

Share On Facebook Share On Twitter

Lars Brzoska is Chairman-Mgmt Board/CEO at Jungheinrich AG.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights from Karan Motwani, CEO of HP Adhesives Ltd, on Innovation, Sustainability, and Leadership | Karan Motwani, CEO, HP Adhesives Ltd.
00:10:00
Matt O'Donnell's Journey: Selling His Business to a Private Equity Strategic Partner
00:10:00
Key Success Factors Driving Cool Caps Industries' 48% Annual Growth | Mr. Rajeev Goenka, Chairman, Cool Caps Industries.
00:10:00
Investing in Education: Understanding the 529 Plan with Smitha Walling of Vanguard | Smitha Walling - Head of Education Savings, Vanguard
00:10:00
Blue Jay Mining: Advancing High-Grade Ilmenite Assets in Greenland
00:10:00
The background of a firm or company make a significance difference|Chris Harper,Senior Associate, Torch Capital
00:00:00
Stefan Weber, CEO, Newron Pharmaceuticals
00:10:00
Watch CEO Chris Bursey's complete OTCQXVideo interview as Remark Holdings, Inc. is welcomed with enthusiasm.
00:10:00
"IoT Talks 2023 features Kjell Johnsen, CEO of Tele2."|Kjell Morten Johnsen is the CEO of Tele2
00:10:00
"Peter Haddock engages in a conversation with newly appointed CEO of Speedy Services, Dan Evans, at Speedy Expo in Liverpool, alongside representatives from Balfour Beatty plc and Matt Seaman."
00:10:00
Timing and Serendipity: David Solomon's Journey to CEO of Goldman Sachs | David Solomon, CEO, Goldman Sachs.
00:10:00
Keynote Remarks by Justin G. Muzinich, Deputy Secretary of the Treasury: Addressing Financial Stability and Policy | Justin Muzinich - Chief Executive Officer

© 2017 - Neuhu+